日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer.

MET-EGFR双重联合抑制对抗T790M-EGFR介导的厄洛替尼耐药肺癌

Tang Z, Du R, Jiang S, Wu C, Barkauskas D S, Richey J, Molter J, Lam M, Flask C, Gerson S, Dowlati A, Liu L, Lee Z, Halmos B, Wang Y, Kern J A, Ma P C

Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion.

小细胞肺癌中 c-MET/HGF 通路的下游信号传导和特异性抑制:对肿瘤侵袭的影响

Ma P C, Tretiakova M S, Nallasura V, Jagadeeswaran R, Husain A N, Salgia R

Fibronectin enhances viability and alters cytoskeletal functions (with effects on the phosphatidylinositol 3-kinase pathway) in small cell lung cancer

纤连蛋白可增强小细胞肺癌细胞的活力并改变细胞骨架功能(影响磷脂酰肌醇3-激酶通路)。

Kijima, T; Maulik, G; Ma, P C; Madhiwala, Priya; Schaefer, E; Salgia, R

Activated c-Met signals through PI3K with dramatic effects on cytoskeletal functions in small cell lung cancer

活化的c-Met通过PI3K信号通路对小细胞肺癌中的细胞骨架功能产生显著影响

Maulik, G; Madhiwala, P; Brooks, S; Ma, P C; Kijima, T; Tibaldi, E V; Schaefer, E; Parmar, K; Salgia, R